These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Efficacy and Safety of Terlipressin Infusion in Hepatorenal Syndrome-Acute Kidney Injury (HRS-AKI): A Retrospective Observational Study. Gowda M; Dilipbhai DM; Jalihal U; Kumar MP; Gowda S B; Jain A; Ganjoo N Cureus; 2024 Aug; 16(8):e66581. PubMed ID: 39252705 [TBL] [Abstract][Full Text] [Related]
24. Outcomes of patients with hepatorenal syndrome undergoing liver transplantation in the era of terlipressin. Terbah R; Cao J; Wong D; Lim PCH; Gow P; Testro A; Sinclair M Eur J Gastroenterol Hepatol; 2023 Aug; 35(8):881-888. PubMed ID: 37395241 [TBL] [Abstract][Full Text] [Related]
25. Impact of terlipressin infusion during and after live donor liver transplantation on incidence of acute kidney injury and neutrophil gelatinase-associated lipocalin serum levels: A randomized controlled trial. Kandil MA; Abouelenain KM; Alsebaey A; Rashed HS; Afifi MH; Mahmoud MA; Yassen KA Clin Transplant; 2017 Aug; 31(8):. PubMed ID: 28564127 [TBL] [Abstract][Full Text] [Related]
26. Pharmacological Therapies for Hepatorenal Syndrome: A Systematic Review and Meta-Analysis. Nanda A; Reddy R; Safraz H; Salameh H; Singal AK J Clin Gastroenterol; 2018 Apr; 52(4):360-367. PubMed ID: 28991106 [TBL] [Abstract][Full Text] [Related]
27. Efficacy and safety of terlipressin in cirrhotic patients with variceal bleeding or hepatorenal syndrome. Krag A; Borup T; Møller S; Bendtsen F Adv Ther; 2008 Nov; 25(11):1105-40. PubMed ID: 19018483 [TBL] [Abstract][Full Text] [Related]
28. Terlipressin in 30 patients with hepatorenal syndrome: results of a retrospective study. von Kalckreuth V; Glowa F; Geibler M; Lohse AW; Denzer UW Z Gastroenterol; 2009 Jan; 47(1):21-6. PubMed ID: 19156588 [TBL] [Abstract][Full Text] [Related]
29. Midodrine in the prevention of hepatorenal syndrome type 2 recurrence: a case-control study. Alessandria C; Debernardi-Venon W; Carello M; Ceretto S; Rizzetto M; Marzano A Dig Liver Dis; 2009 Apr; 41(4):298-302. PubMed ID: 19158001 [TBL] [Abstract][Full Text] [Related]
30. The Treatment of Hepatorenal Syndrome. Cavallin M; Fasolato S; Marenco S; Piano S; Tonon M; Angeli P Dig Dis; 2015; 33(4):548-54. PubMed ID: 26159272 [TBL] [Abstract][Full Text] [Related]
31. An open label, pilot, randomized controlled trial of noradrenaline versus terlipressin in the treatment of type 1 hepatorenal syndrome and predictors of response. Sharma P; Kumar A; Shrama BC; Sarin SK Am J Gastroenterol; 2008 Jul; 103(7):1689-97. PubMed ID: 18557715 [TBL] [Abstract][Full Text] [Related]
32. Noradrenaline is as Effective as Terlipressin in Hepatorenal Syndrome Type 1: A Prospective, Randomized Trial. Goyal O; Sidhu SS; Sehgal N; Puri S J Assoc Physicians India; 2016 Sep; 64(9):30-35. PubMed ID: 27762512 [TBL] [Abstract][Full Text] [Related]
33. Feasibility and Effectiveness of Norepinephrine Outside the Intensive Care Setting for Treatment of Hepatorenal Syndrome. Kwong A; Kim WR; Kwo PY; Wang U; Cheng X Liver Transpl; 2021 Aug; 27(8):1095-1105. PubMed ID: 33837624 [TBL] [Abstract][Full Text] [Related]
34. Comparative efficacy of terlipressin and norepinephrine for treatment of hepatorenal syndrome-acute kidney injury: A systematic review and meta-analysis. Olson JC; Subramanian RM PLoS One; 2024; 19(1):e0296690. PubMed ID: 38285703 [TBL] [Abstract][Full Text] [Related]
35. Terlipressin versus other vasoactive drugs for hepatorenal syndrome. Israelsen M; Krag A; Allegretti AS; Jovani M; Goldin AH; Winter RW; Gluud LL Cochrane Database Syst Rev; 2017 Sep; 9(9):CD011532. PubMed ID: 28953318 [TBL] [Abstract][Full Text] [Related]
36. Reversal of hepatorenal syndrome type 1 with terlipressin plus albumin vs. placebo plus albumin in a pooled analysis of the OT-0401 and REVERSE randomised clinical studies. Sanyal AJ; Boyer TD; Frederick RT; Wong F; Rossaro L; Araya V; Vargas HE; Reddy KR; Pappas SC; Teuber P; Escalante S; Jamil K Aliment Pharmacol Ther; 2017 Jun; 45(11):1390-1402. PubMed ID: 28370090 [TBL] [Abstract][Full Text] [Related]
37. Treatment-Related Cost Analysis of Terlipressin for Adults with Hepatorenal Syndrome with Rapid Reduction in Kidney Function. Huang X; Bindra J; Chopra I; Niewoehner J; Wan GJ Adv Ther; 2023 Dec; 40(12):5432-5446. PubMed ID: 37812332 [TBL] [Abstract][Full Text] [Related]